Life Science Leader: Dynamics and Value of Cross-Border Biotech

Back Bay CEO Jonathan Gertler recently penned “The Dynamics And Value Of Cross-Border Biotech" for Life Science Leader. In it, Dr. Gertler explores the globalization of biotech in relation to the robust Danish biotech sector.He outlines the topics discussed at a Back Bay life science symposium, held in Copenhagen last fall, in which global biotech leaders shared their insights on cross-border development.Dr. Gerter writes, “Biotech success comes to those who extend across borders with the right partners in development and commercialization. The consensus across the symposium — which included acquirers, partners, global investors, and smaller innovators — was that the ethos of ‘going it alone’ can limit success. Instead, start dialogues and create partnerships with international investors and companies before full value is realized.”The article is available to Life Science Leader subscribers here.